Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers-Reference-Cited by-同舟云学术

Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers

Published:2016-02-09 Issue:6 Volume:30 Page:1344-1354
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Granados D P,Rodenbrock A,Laverdure J-P,Côté C,Caron-Lizotte O,Carli C,Pearson H,Janelle V,Durette C,Bonneil E,Roy D C,Delisle J-S,Lemieux S,Thibault P,Perreault C^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201622.pdf

Reference58 articles.

1. Schumacher TN, Schreiber RD . Neoantigens in cancer immunotherapy. Science 2015; 348: 69–74.

2. Rosenberg SA, Restifo NP . Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015; 348: 62–68.

3. Sharma P, Allison JP . The future of immune checkpoint therapy. Science 2015; 348: 56–61.

4. Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 2013; 368: 1509–1518.

5. Maus MV, Fraietta JA, Levine BL, Kalos M, Zhao Y, June CH . Adoptive immunotherapy for cancer or viruses. Annu Rev Immunol 2014; 32: 189–225.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minor histocompatibility antigens to predict, monitor or manipulate GvL and GvHD after allogeneic hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-06

2. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens;Blood;2024-05-02

3. The Scientific Rationale for Targeting Tumor‐Associated Antigens;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Minor histocompatibility antigens represented in HLA-A*02:01 and their search strategies;Oncohematology;2023-09-13

5. BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens;Genome Biology;2023-08-15